Our advanced clinical dashboard enables urologists to identify patients with metastatic castration resistant prostate cancer (mCRPC).
Our AI platform helps identify high-risk patients, allowing the physician to advance treatment along the care pathway.
Participation is easy. Fill in the form below, and then book a time to get started. We review results with you on a regular basis to answer any questions about the dashboard or the clinical criteria.